Ryder, R E J <br/><br/>
Pioglitazone: reports of its death are greatly exaggerated - it is alive and ready to resume saving lives.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Apr 2015 
 - e9-e15 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.12736  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinogens--toxicity<br/>Diabetic Angiopathies--prevention & control<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Observational Studies as Topic<br/>Pioglitazone<br/>Randomized Controlled Trials as Topic<br/>Rats<br/>Risk Factors<br/>Safety-Based Drug Withdrawals<br/>Thiazolidinediones--adverse effects<br/>Urine